To explore the role of SMYD3-ANKHD1 in determining clinical outcomes for HCC patients, we assessed the correlation between SMYD3-ANKHD1 and the prognosis of 243 HCC patients. The gene discussed is SMYD3; the disease is hepatocellular carcinoma.